Galamon, Renaldo A.
HRN: 23-54-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2023
CEFUROXIME 750MG (VIAL)
08/18/2023
08/25/2023
IVTT
700mg
Q8
Intestinal Parasitism
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes